Target intelligence / Profile preview

Tetratricopeptide repeat domain 21A (TTC21A)

Target
TTC21A
Molecular classification
Other (TPR domain-containing scaffold protein), Intraflagellar transport (IFT) protein complex component
01

Overview

Tetratricopeptide repeat domain 21A (TTC21A) is a protein-coding gene that encodes a member of the tetratricopeptide repeat (TPR) protein family, which primarily functions as a scaffold for protein-protein interactions. TTC21A is a component of the intraflagellar transport particle A (IFT-A) complex, playing a critical role in the formation and function of motile cilia, notably in sperm flagellar motility and spermiogenesis. It is highly expressed in tissues with active cilia, such as testis, and its dysfunction is implicated in spermatogenic failure (SPGF37) and oligospermia. Recent studies suggest TTC21A may also have prognostic value in colorectal cancer, where elevated expression levels correlate with poorer overall survival and possible influence on tumor immunity, although it is not a direct therapeutic target. Currently, no drugs are known to target TTC21A directly, and its primary relevance is as a research subject in cell biology and disease biomarker studies rather than as a therapeutic target.

Other names
Tetratricopeptide repeat protein 21AStress-inducible protein 2STI2Thm2IFT139ATPR repeat protein 21ASPGF37testicular tissue protein Li 212Ttc21a-ps14921538N17RikRGD1308806
02

Biological functions

Sperm flagellar formationSpermatogenesisSpermatid developmentIntraflagellar transport (IFT) within cilia
03

Disease associations

Male infertility (spermatogenic failure 37)Possible roles in cancer (e.g., colorectal cancer prognosis)Other
04

Biomarkers

Potential prognostic biomarker for colorectal cancer (high expression associated with shorter survival)

Beyond the preview

Go deeper on Tetratricopeptide repeat domain 21A (TTC21A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetratricopeptide repeat domain 21A (TTC21A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call